Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.90 is in line with its 5-year average of 4.06, near the low end of its 5-year range (3.24–6.33).
As of the fiscal period ended Tuesday, June 30, 2026. 3.29% above its 12-month average of 3.78.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.90.
CURRENT RATIO
3.90
CURRENT RATIO AVG TTM
3.78
CURRENT RATIO AVG 3Y
3.83
CURRENT RATIO AVG 5Y
4.06
CURRENT RATIO AVG 10Y
6.22
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+3.29%
CURRENT VS 3Y AVG
+1.82%
CURRENT VS 5Y AVG
-3.86%
CURRENT VS 10Y AVG
-37.20%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.60
median of 795 covered companies
CURRENT VS SECTOR MEDIAN
+8.46%
vs the sector median at left
Kiniksa Pharmaceuticals International, plc
Market Cap
$5.76B
Current Ratio
3.90
TTM Avg
3.78
3Y Avg
3.83
5Y Avg
4.06
Market Cap
$5.91B
Current Ratio
4.35
TTM Avg
3.47
3Y Avg
3.74
5Y Avg
5.38
Market Cap
$5.94B
Current Ratio
31.18
TTM Avg
15.58
3Y Avg
12.00
5Y Avg
10.69
Market Cap
$5.52B
Current Ratio
1.81
TTM Avg
1.62
3Y Avg
1.66
5Y Avg
1.66
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | $5.76B | 3.90 | 3.78 | 3.83 | 4.06 |
| CG Oncology Inc. (CGON)vs › | $5.67B | 22.22 | 29.96 | 20.77 | 18.57 |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.91B | 4.35 | 3.47 | 3.74 | 5.38 |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.94B | 31.18 | 15.58 | 12.00 | 10.69 |
| RadNet, Inc. (RDNT)vs › | $5.53B | 1.48 | 1.94 | 1.50 | 1.26 |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | 1.81 | 1.62 | 1.66 | 1.66 |
| GRAIL Inc. (GRAL)vs › | $6.02B | 10.95 | 11.32 | 6.44 | 5.89 |
| Doximity, Inc. (DOCS)vs › | $5.32B | 6.08 | 6.53 | 6.56 | 6.07 |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.30B | 3.39 | 2.35 | 2.11 | 2.46 |
| Sotera Health Company (SHC)vs › | $5.27B | 2.80 | 2.60 | 2.11 | 2.14 |
Current Ratio
3.90
Quick Ratio
3.49
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.90 |
| 2026-03-31 | 3.79 |
| 2025-12-31 | 3.79 |
| 2025-09-30 | 3.85 |
| 2025-06-30 | 3.57 |
| 2025-03-31 | 3.66 |
| 2024-12-31 | 3.30 |
| 2024-09-30 | 3.24 |
| 2024-06-30 | 3.57 |
| 2024-03-31 | 4.21 |
| 2023-12-31 | 4.34 |
| 2023-09-30 | 4.79 |
| 2023-06-30 | 5.18 |
| 2023-03-31 | 6.33 |
| 2022-12-31 | 5.16 |
| 2022-09-30 | 4.28 |
| 2022-06-30 | 4.13 |
| 2022-03-31 | 3.95 |
| 2021-12-31 | 4.38 |
| 2021-09-30 | 6.32 |
| 2021-06-30 | 6.31 |
| 2021-03-31 | 7.77 |
| 2020-12-31 | 10.46 |
| 2020-09-30 | 15.20 |
| 2020-06-30 | 12.87 |
| 2020-03-31 | 11.02 |
| 2019-12-31 | 8.68 |
| 2019-09-30 | 9.74 |
| 2019-06-30 | 9.82 |
| 2019-03-31 | 9.08 |
| 2018-12-31 | 7.37 |
| 2018-09-30 | 12.19 |
| 2018-06-30 | 15.72 |
| 2018-03-31 | 11.55 |
| 2017-12-31 | 2.70 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
